The Venture Codex Logo

The Venture Codex

Intrepid Growth Partners

108 College St, Suite W520, Toronto, ON, M5G 0C6, Canada

Overview

Intrepid Growth Partners provides growth capital and supports AI leaders at the growth stage. The firm is composed of seasoned investors with extensive backgrounds in globally recognized institutions and has over three decades of experience in creating and managing investment teams.

Total investments
7
Lead investments
2
Investments · 12mo
5
Active investors
3

Sector focus

  • Business Development
  • Finance
  • Financial Services
Visit website

Investment portfolio

  • Beacon Software

    Participated · Series C · Jun 2026

    Beacon grows via a model of selectively acquiring mission-critical businesses and integrating them into a shared, AI-native operating platform. The company says it is acquiring businesses at a pace of roughly one per week and that its modernization approach produced more than +50% EBITDA growth over the last year. Beacon plans to use the new funding to accelerate development of its AI-native business operating system and to continue acquiring essential businesses. Beacon has expanded its executive team with Mark Schaaf joining as COO/CPO and Goutham Buchi as CTO and opened a San Francisco office. The company reported raising over half a billion dollars in the past year. The articles do not disclose founding year or a valuation.

  • PhysicsX

    Participated · Series C · Jun 2026

    PhysicsX offers an AI-based engineering platform that predicts physical behavior in seconds rather than hours or days, enabling engineers to test many more design variations. Its platform is used across aerospace and defense, semiconductors, industrial machinery, automotive, energy and materials. The company plans to expand its platform capabilities, develop larger pre-trained "Large Physics Models," and grow its geographic presence including the U.S. and a new office in Singapore. Recent financing will fund that expansion and product development. Financially, PhysicsX reported rapid commercial momentum: it doubled recognized revenue and tripled booked revenue in the past year while more than doubling its customer count. The company has grown its team to over 300 employees in the last 12 months.

  • Iterative Health

    Led · Series C · Apr 2026

    Iterative Health combines centralized operations, expert staffing, proprietary AI technology, and clinical trial expertise to operate a multispecialty clinical research network that embeds research into routine care. Its global network includes more than 100 research sites across North America, Europe, India, and Australia and partnerships with over 40 pharmaceutical, biotech, medical device, and CRO organizations. The company reports delivering 2x faster site activation for IBD trials and 3x higher patient enrollment rates compared to industry benchmarks, with an average of more than two IBD patients randomized every business day across the network. Iterative Health's model centers on site success to improve trial execution reliability at scale. The company plans to expand beyond gastroenterology and hepatology into cardiology and obesity while continuing geographic expansion and broader provider partnerships. Iterative Health is headquartered in Cambridge, Massachusetts and New York, New York.

  • Exein

    Participated · Equity · Dec 2025

    Exein develops an embedded, hardware-agnostic cybersecurity platform that integrates runtime security directly into device firmware, allowing connected devices to detect, contain and respond to threats even when offline. The system already safeguards more than 1.5 billion devices in sectors such as energy, healthcare, defence, automotive, aerospace and industrial automation, and the company projects this figure will surpass two billion in Q1 2026. Exein’s technology supports integrity checks across supply chains and helps manufacturers comply with regulations like RED 3.3, the forthcoming EU Cyber Resilience Act and the US Cyber Trust Mark. Looking ahead, the firm plans to release next-generation protections for on-device AI and large language models, with an initial unveiling slated for RSAC 2026. The new capital will also fund a multi-transaction M&A programme in 2026 and accelerate expansion in the US and APAC. Exein has experienced a significant valuation uplift since mid-2025, reflecting rising demand for device-level security and its strengthened commercial position.

  • CoLab Software

    Led · Series C · Nov 2025

    Founded in 2017, CoLab Software builds EngineeringOS, a cloud workspace that lets engineers run design reviews, annotate 2D/3D files, and apply AI agents to improve product quality. Its first agent, AutoReview, launched in June and already has more than 47,000 engineers on its waitlist, while early customers such as Ford, Lockheed Martin, GE Appliances, and Schneider Electric are using the core platform today. Management says these capabilities enable customers to shrink design cycles from months to hours and are driving seven-figure annual contracts. The company reports it is on track to nearly triple revenue in 2025, reflecting strong demand for AI in engineering workflows. CoLab plans to roll out additional AI agents, deepen integrations with other engineering software, and announce several strategic partnerships over the next 12 months. The platform also addresses a looming retirement-driven knowledge gap by capturing expert rationale that can be reused by future engineers.

Team